Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. - Wikidata - wikimedia - TriplyDB

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

http://www.wikidata.org/entity/Q35083250

about

Clinical relevance of SKP2 alterations in metastatic melanoma Mitf regulation of Dia1 controls melanoma proliferation and invasiveness A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.Proteomics of breast cancer: principles and potential clinical applications.Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.Gene expression profiling of melanocytes following Q-Switched Ruby laser irradiation.Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.Primary cutaneous melanoma: an 18-year study.B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells Diagnostic and prognostic biomarkers in melanoma.Tailoring to RB: tumour suppressor status and therapeutic response.The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.A gene expression signature associated with survival in metastatic melanoma Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies Biomarkers as key contributors in treating malignant melanoma metastases.P16 protein expression in primary cutaneous melanoma with positive and negative lymph node biopsies: Particular aspects of a study performed at the Hospital de Clinicas de Porto Alegre, Brazil Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.Applications of array technology: melanoma research and diagnosis.Genetic pathways to melanoma tumorigenesis.A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines Tissue microarrays: fast-tracking protein expression at the cellular level.Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.Role of nuclear factor-kappa B in melanoma.Tissue microarrays: bridging the gap between research and the clinic.Technology insight: Identification of biomarkers with tissue microarray technology.Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer.Tissue microarrays in clinical oncology What brown cannot do for you.Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.Immunohistochemical expression of Skp2 protein in oral nevi and melanoma Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.Melanoma biomarkers: current status and vision for the future.Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.Melanoma prognostic model using tissue microarrays and genetic algorithms.Construction and analysis of multiparameter prognostic models for melanoma outcome

P2860

Q24630149-CB308F0C-1DC0-43A0-9D2D-B713B4048C86 Q24672631-6DF1ABC7-9361-48B6-A5E7-FBAB6CBCA8B4 Q28728722-7B11E334-AA45-4DD3-ABFE-7D1446A20997 Q33228633-CAD106A8-A13C-4819-88E9-4F6D8781CF6C Q33245053-25A17005-DA0D-46AD-A385-11651AD3A49E Q33289108-9F199A76-74FE-40DF-A24F-082F2463F6FA Q33306797-B6FFE9E5-96DE-4D1B-B850-7CB782AD4AD0 Q33315713-376E29BB-205C-404A-80A1-360AB5B2C088 Q33647719-ADCFFE35-8E6F-495D-8D22-2CACB24C6E95 Q33754062-301F6D1B-7836-4C16-80EA-ECE81E6DC240 Q33786387-CF966AAB-E29A-4E9A-9E57-FE38D8C453CD Q33862470-AA0E7219-9B62-441E-94D1-C3870123B00B Q34040108-80A56DB9-E1D9-458F-97D7-5075F6E07980 Q34459058-D40309C4-548F-4AA1-9F2C-8D00031586AB Q34551677-F7C6B1DC-BBDC-45D4-B68B-9AA4BFD62764 Q35220047-1CCC1716-5E01-483E-A32A-D1CE3731740E Q35234354-C765AE16-5159-42C8-9588-946152192EBC Q35245799-44CE2B7A-3B9C-4C43-AF04-FBC1F6281773 Q35550888-ACFD20E6-E31F-4C8B-9610-3C54053E6278 Q35716915-DA97A727-3046-4401-AD95-498567D7C21E Q35770092-5CB3B583-1AC5-45E1-BEEA-3931D3824BB6 Q35821854-C88246A0-AFC8-4C12-AFEE-3A57469BCC95 Q35848850-48D3EE16-7430-407A-8C90-C01245EF1D21 Q36096818-795FD4F9-1D6D-43E6-B741-0D6F8032F766 Q36168371-D45456FD-769B-4D27-8421-A3B3E81803C9 Q36174359-7A7DCBAF-40A7-4C47-8D1C-44C08D5BD13D Q36178379-B0D0AD15-AEBB-495A-9C21-F5B6C81ADD42 Q36184792-3B003FFD-0FD7-40C8-9738-715822DC13BA Q36303882-1A5A5988-DD3C-4BC0-8B0A-A278BD8E047D Q36430872-5B560603-F5B3-43D9-83EC-3000AEB741A3 Q36537565-FCCC2AB5-9299-41B6-B5CC-E2C6AE2E355D Q36561615-E1260403-8577-48D0-A162-ACC5FE75E4F2 Q36707344-C4CE41F5-75C4-4C6A-97F7-CC3392152FF7 Q36768291-8F445E7C-3EE2-4808-9C9B-6D5AE74D99FE Q36891169-A4EA056D-2D94-41D7-BAAE-9E1DCE8A8D71 Q37288883-9BC06CEC-9846-4739-9925-FEB3155D4693 Q37357928-5706A205-CCC7-40C7-8FDB-8959401B40DE Q37388126-5DBF5492-6433-461F-8B30-D7EE06CA9FEE Q37474252-D26DD20E-178C-4472-A6B9-35234FEE7654 Q37550749-3AA4B826-B726-42C2-A59D-6068ECA78E0D

P2860

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

http://www.wikidata.org/entity/Q35083250

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Progression in cutaneous malig ...... tissue microarray-based study.

@ast

Progression in cutaneous malig ...... tissue microarray-based study.

@en

type

label

Progression in cutaneous malig ...... tissue microarray-based study.

@ast

Progression in cutaneous malig ...... tissue microarray-based study.

@en

prefLabel

Progression in cutaneous malig ...... tissue microarray-based study.

@ast

Progression in cutaneous malig ...... tissue microarray-based study.

@en

P1433

Q35083250-802BB1AD-1BF3-48B8-8DA9-843B729CE07F

P1476

Q35083250-416A2BA6-415C-4F99-8188-75AD5BACB8AA

P2093

Q35083250-18FBCC1E-3866-405F-847F-89AFC8C075C4

Q35083250-1E1D3B79-F374-45DD-9A7F-B3274DD10F9D

Q35083250-367EE0B4-65E4-46F8-B73B-9F1989981261

Q35083250-6BB3B330-1399-4AD9-A3A5-90A2AC4DB341

Q35083250-86204A97-36F6-41F6-BDD3-4BA418E23385

Q35083250-87B62343-0BB3-441F-B408-A7FC9E422537

Q35083250-A3EE4A5C-B9B9-4C5A-B4B0-45504FB45F92

Q35083250-CB4D8287-3532-477E-98F4-EEBEE5B5BAE7

P2860

Q35083250-21C7F6D9-B760-4DBE-9763-0E08043BC961

Q35083250-24A32152-48F3-415C-9B0F-38ED17A120A2

Q35083250-28D66610-03D4-465C-9005-02B2395626B0

Q35083250-2E5E9F5E-A518-45C5-AE56-FD48E7909B12

Q35083250-348404F9-0D2E-46E2-BBD4-5FE463E70252

Q35083250-348B36E2-92A2-4A5B-AB16-90FE9B52B8A1

Q35083250-4142EF89-EE8F-4B4C-B5AC-58B968DE6EE3

Q35083250-49F3E94F-AFDB-49D7-BFF2-1785ED3A33B8

Q35083250-4DDAAC0F-05BE-4381-8DE5-F85F61FE2A6C

Q35083250-53D66884-3B4F-4A80-8DC2-D03D305DFCE7

P304

Q35083250-90E3A835-C34F-475A-BA5A-2F2567A1A866

P31

Q35083250-742D6245-9F3C-4BCB-AE44-0707BD24C00D

P356

Q35083250-2E83B5E3-0C6D-4876-B21F-B7C226D1BF65

P407

Q35083250-22247298-8B6C-4F04-9DE6-4E6C517C1083

P433

Q35083250-079DF379-418D-46E1-91B9-052A26F145C6

P478

Q35083250-F7D16DF8-01B4-4905-B450-63B57E17CC4C

P50

Q35083250-5F310AFB-F1D2-41B2-9AFB-4B24F546E435

Q35083250-622652C7-F317-4D38-87E3-DB569A30EEFD

Q35083250-CA6DBAA3-A23F-40E3-9EE4-748D2C6B83EF

P577

Q35083250-0D9352F1-32B7-4B3E-ACF2-208B4C9A6E33

P698

Q35083250-418569F1-6B42-4A0B-946C-6291CD1CB428

P932

Q35083250-B75FB126-08F1-495E-A4BD-DACDBC2CEFD6

P356

S0002-9440(10)63110-0

P1433

The American Journal of Pathology

P1476

Progression in cutaneous malig ...... tissue microarray-based study

@en

P2093

Carlos M Hortelano

http://www.w3.org/2001/XMLSchema#string

Francisco J Martínez-Tello

http://www.w3.org/2001/XMLSchema#string

Lydia Sánchez

http://www.w3.org/2001/XMLSchema#string

Ma Jesús Acuña

http://www.w3.org/2001/XMLSchema#string

Miguel A Piris

http://www.w3.org/2001/XMLSchema#string

Pablo Ortiz

http://www.w3.org/2001/XMLSchema#string

Raquel Pajares

http://www.w3.org/2001/XMLSchema#string

Soledad R Alonso

http://www.w3.org/2001/XMLSchema#string

P2860

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.

Invasive melanoma in Cdk4-targeted mice.

To cycle or not to cycle: a critical decision in cancer.

Murine models of malignant melanoma.

Genetic dissection of melanoma pathways in the mouse.

Reduction of caveolin and caveolae in oncogenically transformed cells

P304

193-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63110-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

Beatriz Pérez-Gómez

José Luis Rodríguez-Peralto

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14695333

http://www.w3.org/2001/XMLSchema#string

P932

1602212

http://www.w3.org/2001/XMLSchema#string